Category : Diet

Dr. Gary D. Wu is a Professor in Gastroenterology at the University of Pennsylvania and currently Director and Chair of the Scientific Advisory Board for the American Gastroenterological Association Center for Gut Microbiome Research and Education. His research examines interactions between gut microbiota and host, particularly focusing on diet and metabolism. Dr. Wu gave a talk at Experimental Biology 2015…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Dr. Gary D. Wu is a Professor in Gastroenterology at the University of Pennsylvania and currently Director and Chair of the Scientific Advisory Board for the American Gastroenterological Association Center for Gut Microbiome Research and Education. His research examines interactions between gut microbiota and host, particularly focusing on diet and metabolism. Dr. Wu gave a talk at Experimental Biology 2015…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Liping Zhao and colleagues, in their recent paper on a dietary intervention for simple and genetic obesity, discussed evidence for the existence of gut microbiota 'guilds': bacterial genomes within the gut ecosystem that responded to the dietary intervention as a group. Zhao further explains to GMFH editors, "Guilds are functional groups formed by different species in an ecosystem. Members in…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Liping Zhao and colleagues, in their recent paper on a dietary intervention for simple and genetic obesity, discussed evidence for the existence of gut microbiota 'guilds': bacterial genomes within the gut ecosystem that responded to the dietary intervention as a group. Zhao further explains to GMFH editors, "Guilds are functional groups formed by different species in an ecosystem. Members in…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

A recent study lent insight into the role of the microbiota in both diet-related and genetic obesity in humans. This Chinese study, led by Prof. Liping Zhao, Prof. Aihua Yin, and Prof. Huiru Tang, involved 17 children with Prader-Willi syndrome (PWS) -- the most common genetic cause of morbid obesity in children -- and 21 with simple (diet-induced) obesity. The…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

A recent study lent insight into the role of the microbiota in both diet-related and genetic obesity in humans. This Chinese study, led by Prof. Liping Zhao, Prof. Aihua Yin, and Prof. Huiru Tang, involved 17 children with Prader-Willi syndrome (PWS) -- the most common genetic cause of morbid obesity in children -- and 21 with simple (diet-induced) obesity. The…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Dr. Stephen J.D. O'Keefe is a Professor of Medicine at the University of Pittsburgh and a practicing gastroenterologist at the University of Pittsburgh Medical Center. His work focuses on 'nutritional gastroenterology' -- in particular, translational research that evaluates physiological and pathophysiological responses to dietary intake. Dr. O'Keefe gave a talk at Experimental Biology 2015 called, "Diet, Microbiota, and Microbial Metabolites in Rural…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Dr. Stephen J.D. O'Keefe is a Professor of Medicine at the University of Pittsburgh and a practicing gastroenterologist at the University of Pittsburgh Medical Center. His work focuses on 'nutritional gastroenterology' -- in particular, translational research that evaluates physiological and pathophysiological responses to dietary intake. Dr. O'Keefe gave a talk at Experimental Biology 2015 called, "Diet, Microbiota, and Microbial Metabolites in Rural…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

When Dr. Deanna Gibson began studying patients with inflammatory bowel disease (IBD), she found it strange that scientists knew very little about how diet -- a controllable factor -- could alter gut microbes and gut immune responses. "[In] inflammatory bowel diseases, we know that environment is playing a role. The sheer dramatic rise in the incidence of them cannot be…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

When Dr. Deanna Gibson began studying patients with inflammatory bowel disease (IBD), she found it strange that scientists knew very little about how diet -- a controllable factor -- could alter gut microbes and gut immune responses. "[In] inflammatory bowel diseases, we know that environment is playing a role. The sheer dramatic rise in the incidence of them cannot be…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Previous research has shown that adults with irritable bowel syndrome (IBS) who adopt a low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diet show an improvement in symptoms within 2 days. Would the low FODMAP diet have the same effect in childhood IBS? Does the gut microbiota predict the success of the diet in children who respond to this dietary intervention?…

James Versalovic
Dr. James Versalovic received his M.D. with Honors at Baylor College of Medicine (BCM) in 1995 and his Ph.D. in Cellular and Molecular Biology at BCM in 1994. He pursued clinical pathology/medical microbiology residency training at the Massachusetts General Hospital and Harvard Medical School. He also received postdoctoral research training in the Division of Comparative Medicine at the Massachusetts Institute of Technology (MIT). Dr. Versalovic joined the medical staff as a clinical pathologist at the Massachusetts General Hospital and served as Assistant Professor of Pathology at Harvard Medical School from 1999-2001. He is board-certified in clinical pathology, molecular genetic pathology, and molecular diagnostics. Dr. Versalovic currently serves as Pathologist-In-Chief, Head of the Department of Pathology, and as member of the Board of Directors at Texas Children’s Hospital. He also serves as Vice Chair of Molecular Pathology and Omics at BCM, and Director of the Texas Children’s Microbiome Center. He holds the Milton J. Finegold endowed chair as Professor of Pathology & Immunology, and Professor of Pediatrics, Molecular and Human Genetics, and Molecular Virology & Microbiology at Baylor College of Medicine. He is Co-Director of the Medical Scientist (MD/PhD) Training Program at Baylor. He served as Editor-in-Chief of the Manual of Clinical Microbiology and Editor of Therapeutic Microbiology: Probiotics and Related Strategies. As a Principal Investigator, his primary research interests include the human microbiome, probiotics, medical and molecular microbiology, innate immunity, digestive diseases, and gastrointestinal physiology. His research program has been supported by the U.S. National Institutes of Health, Department of Defense, and Crohn’s and Colitis Foundation of America. Dr. Versalovic has authored 131 primary manuscripts, 34 book chapters, and 2 patents. He received the Lansky Award as a national leader in pathology under the age of 45 from the College of American Pathologists Foundation. He also received the BioGaia Ivan Casas Probiotics Research Award and the BCM Graduate School of Biomedical Sciences Distinguished Alumnus Award.

Previous research has shown that adults with irritable bowel syndrome (IBS) who adopt a low FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides and polyols) diet show an improvement in symptoms within 2 days. Would the low FODMAP diet have the same effect in childhood IBS? Does the gut microbiota predict the success of the diet in children who respond to this dietary intervention?…

James Versalovic
Dr. James Versalovic received his M.D. with Honors at Baylor College of Medicine (BCM) in 1995 and his Ph.D. in Cellular and Molecular Biology at BCM in 1994. He pursued clinical pathology/medical microbiology residency training at the Massachusetts General Hospital and Harvard Medical School. He also received postdoctoral research training in the Division of Comparative Medicine at the Massachusetts Institute of Technology (MIT). Dr. Versalovic joined the medical staff as a clinical pathologist at the Massachusetts General Hospital and served as Assistant Professor of Pathology at Harvard Medical School from 1999-2001. He is board-certified in clinical pathology, molecular genetic pathology, and molecular diagnostics. Dr. Versalovic currently serves as Pathologist-In-Chief, Head of the Department of Pathology, and as member of the Board of Directors at Texas Children’s Hospital. He also serves as Vice Chair of Molecular Pathology and Omics at BCM, and Director of the Texas Children’s Microbiome Center. He holds the Milton J. Finegold endowed chair as Professor of Pathology & Immunology, and Professor of Pediatrics, Molecular and Human Genetics, and Molecular Virology & Microbiology at Baylor College of Medicine. He is Co-Director of the Medical Scientist (MD/PhD) Training Program at Baylor. He served as Editor-in-Chief of the Manual of Clinical Microbiology and Editor of Therapeutic Microbiology: Probiotics and Related Strategies. As a Principal Investigator, his primary research interests include the human microbiome, probiotics, medical and molecular microbiology, innate immunity, digestive diseases, and gastrointestinal physiology. His research program has been supported by the U.S. National Institutes of Health, Department of Defense, and Crohn’s and Colitis Foundation of America. Dr. Versalovic has authored 131 primary manuscripts, 34 book chapters, and 2 patents. He received the Lansky Award as a national leader in pathology under the age of 45 from the College of American Pathologists Foundation. He also received the BioGaia Ivan Casas Probiotics Research Award and the BCM Graduate School of Biomedical Sciences Distinguished Alumnus Award.

The Third International Congress of Translational Research in Human Nutrition took place in Clermont-Ferrand, France, on June 26 & 27, 2015. In this post, we bring you an overview of three symposia: clinical implication of gut microbiota knowledge, microbiota and non-intestinal diseases, and microbiota and intestinal integrity. Follow this link to read the first part of this report.   Symposium 3…

Amandine Everard
Postdoctoral position, supported by the FNRS (Fond National de la Recherche Scientifique), in the metabolism and nutrition research group (team of Prof. Patrice D. Cani), at the Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL). CERTIFICATE : Master in Pharmaceutical Sciences, Université catholique de Louvain (UCL), 2010 - Doctoral in Biomedical and Pharmaceutical Sciences supervised by the Professor Patrice D. Cani, Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), 2014. RESEARCH INTERESTS: Interactions between gut microbiota and intestinal epithelium in metabolic disorders associated with obesity.

The Third International Congress of Translational Research in Human Nutrition took place in Clermont-Ferrand, France, on June 26 & 27, 2015. In this post, we bring you an overview of three symposia: clinical implication of gut microbiota knowledge, microbiota and non-intestinal diseases, and microbiota and intestinal integrity. Follow this link to read the first part of this report.   Symposium 3…

Amandine Everard
Postdoctoral position, supported by the FNRS (Fond National de la Recherche Scientifique), in the metabolism and nutrition research group (team of Prof. Patrice D. Cani), at the Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL). CERTIFICATE : Master in Pharmaceutical Sciences, Université catholique de Louvain (UCL), 2010 - Doctoral in Biomedical and Pharmaceutical Sciences supervised by the Professor Patrice D. Cani, Louvain Drug Research Institute (LDRI), Université catholique de Louvain (UCL), 2014. RESEARCH INTERESTS: Interactions between gut microbiota and intestinal epithelium in metabolic disorders associated with obesity.

For Catherine Lozupone, formerly a researcher in the Knight and Gordon labs and now faculty at the University of Colorado, characterizing a 'healthy microbiota' or even a 'healthy diet' is far from straightforward. At Experimental Biology 2015 in March, Lozupone presented her research and brought forward a provocative idea: a healthy microbiota is one that matches your diet. She spoke…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

For Catherine Lozupone, formerly a researcher in the Knight and Gordon labs and now faculty at the University of Colorado, characterizing a 'healthy microbiota' or even a 'healthy diet' is far from straightforward. At Experimental Biology 2015 in March, Lozupone presented her research and brought forward a provocative idea: a healthy microbiota is one that matches your diet. She spoke…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Obesity and type 2 diabetes mellitus (T2DM) are complex chronic diseases with rapidly growing prevalence across the world. Human studies have found that both genetic and environmental factors contribute to T2DM; the clearest lifestyle factors are high caloric intake and low physical activity. The mechanisms by which human T2DM arises is still unclear, but obesity, insulin resistance and ß-cell dysfunction…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Obesity and type 2 diabetes mellitus (T2DM) are complex chronic diseases with rapidly growing prevalence across the world. Human studies have found that both genetic and environmental factors contribute to T2DM; the clearest lifestyle factors are high caloric intake and low physical activity. The mechanisms by which human T2DM arises is still unclear, but obesity, insulin resistance and ß-cell dysfunction…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Amir Zarrinpar (MD, PhD) is a gastroenterologist with UC San Diego Health, and a researcher at The Salk Institute for Biological Studies. His mouse research on the role of the gut microbiota in obesity and metabolic disease was presented earlier this year in a short talk at the 2015 Keystone Symposium, Gut Microbiota Modulation of Host Physiology. Zarrinpar answered some questions…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter

Amir Zarrinpar (MD, PhD) is a gastroenterologist with UC San Diego Health, and a researcher at The Salk Institute for Biological Studies. His mouse research on the role of the gut microbiota in obesity and metabolic disease was presented earlier this year in a short talk at the 2015 Keystone Symposium, Gut Microbiota Modulation of Host Physiology. Zarrinpar answered some questions…

Kristina Campbell
Science writer Kristina Campbell (M.Sc.), from British Columbia (Canada), specializes in communicating about the gut microbiota, digestive health, and nutrition. Author of the best selling Well-Fed Microbiome Cookbook, her freelance work has appeared in publications around the world. Kristina joined the Gut Microbiota for Health publishing team in 2014.  Find her on: GoogleTwitter